An analysis of 124 surgically managed brachial artery injuries

R Zellweger, F Hess, A Nicol, J Omoshoro-Jones… - The American journal of …, 2004 - Elsevier
BACKGROUND: A 3-year review of surgically managed brachial artery injuries is presented.
METHODS: The medical records were analyzed for demographic data, mechanism of injury…

[HTML][HTML] Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer

N Elebo, P Fru, J OmoshoroJones… - Molecular …, 2020 - spandidos-publications.com
Pancreatic cancer is an aggressive cancer, making it a leading cause of cancer‑related
deaths. It is characteristically resistant to treatment, which results in low survival rates. In …

[HTML][HTML] Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study

…, A Ivanecz, A Antonucci, JAO Omoshoro-Jones… - Hpb, 2017 - Elsevier
Background The aim of the study was to evaluate the current opinion and clinical decision-making
process of international pancreatologists, and to systematically identify key study …

[HTML][HTML] Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV

…, S Burmeister, M Bernon, J Omoshoro-Jones… - BMC …, 2020 - Springer
Background Patients co-infected with hepatitis B virus (HBV) and the human immunodeficiency
virus (HIV) are at risk of developing hepatocellular carcinoma (HCC). In sub-Saharan …

[HTML][HTML] Targeting growth factor signaling pathways in pancreatic cancer: towards inhibiting chemoresistance

N Xelwa, GP Candy, J Devar, J Omoshoro-Jones… - Frontiers in …, 2021 - frontiersin.org
Pancreatic cancer is one of the most deadly cancers, ranking amongst the top leading
cause of cancer related deaths in developed countries. Features such as dense stroma …

Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects

…, G Candy, J Devar, J Omoshoro-Jones… - Molecular Biology …, 2020 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest human malignancies with
a dismal prognosis. During PDAC progression, the immune response is affected as cancer …

[HTML][HTML] SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related …

…, S Stoychev, J Devar, DL Tabb, J Omoshoro-Jones… - PLoS …, 2020 - journals.plos.org
Pancreatic cancer accounts for 2.8% of new cancer cases worldwide and is projected to
become the second leading cause of cancer-related deaths by 2030. Patients of African …

[HTML][HTML] Informal caregiver challenges for advanced cancer patients during end-of-life care in Johannesburg, South Africa and distinctions based on place of death

…, H Cubasch, ML Wong, JAO Omoshoro-Jones… - Journal of pain and …, 2018 - Elsevier
Context In sub-Saharan Africa, late diagnosis with cancer is common. Many dying patients
rely on family members for care; little is known about the challenges African informal …

Relationship between low-density lipoprotein cholesterol and severe acute pancreatitis (“the lipid paradox”)

…, S Stock, M Zippi, JAQ Omoshoro-Jones… - … and Clinical Risk …, 2018 - Taylor & Francis
Background and aim The aim of this study was to investigate the association between low-density
lipoprotein cholesterol (LDL-C) and the development of severe acute pancreatitis (SAP…

[HTML][HTML] Serum metabolomic and lipoprotein profiling of pancreatic ductal adenocarcinoma patients of african ancestry

N Elebo, J Omoshoro-Jones, PN Fru, J Devar… - Metabolites, 2021 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a characteristic dysregulated
metabolism. Abnormal clinicopathological features linked to defective metabolic and …